Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Med Vet International Laverdia-Ca1 (Verdinexor) Tablets For Dogs 2.5mg, 50 Count
Supplier: Med Vet International RXLAVERDIA2.5K9
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
Laverdia™-CA1 is the first oral tablet FDA conditionally approved to treat lymphoma in dogs. Verdinexor is a selective inhibitor of nuclear export CRM1/XPO1 protein The active ingredient in Laverdia-CA1 is verdinexor, a substance that works by preventing tumor suppressing proteins from leaving the nucleus of cells, resulting in disruption of cancer cell survival and eventual cancer cell death*Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-526.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?